Skip to main content

Advertisement

Log in

Early gastric cancer with RhoGAP fusion is linked to frequent nodal metastasis and a part of microtubular–mucocellular histology

  • Original Article
  • Published:
Gastric Cancer Aims and scope Submit manuscript

Abstract

Introduction

Gastric cancer with fusion genes involving the Rho GTPase-activating protein domain (RhoGAP-GC) is mainly included in the genomically stable type of The Cancer Genome Atlas classification. Clinical implications and histological characteristics of RhoGAP-GC in the early phase remain unclear.

Methods

We analyzed 878 consecutive pT1b GCs for RhoGAP and its partner genes using fluorescence in situ hybridization assay.

Results

RhoGAP fusion was detected in 57 (6.5%) GCs. Univariate analysis revealed that female sex, middle–lower third tumor location, advanced macroscopic type, tumor diameter > 2 cm, pT1b2, lymphatic invasion, venous invasion, negative EBER-ISH, and RhoGAP fusion were significantly associated with lymph node metastasis (LNM). Multivariate analysis presented RhoGAP fusion, lymphatic invasion, tumor diameter > 2 cm, advanced macroscopic type, venous invasion, and middle–lower third tumor location as independent risk factors for LNM. Notably, RhoGAP fusion had the highest odds ratio (3.92) for LNM among analyzed parameters (95% CI 2.12–7.27; p < 0.001). Compared to non-RhoGAP-GCs, RhoGAP-GCs were significantly frequent in younger females and showed the highest incidence of lymphatic invasion (56.2%) and LNM (49.1%) (p < 0.001). Histologically, microtubular architecture with pseudo-trabecular interconnection and small aggregations of tumor cells with a varied amount of cytoplasmic mucin, named “microtubular–mucocellular (MTMC) histology,” was found in 93.0% (53 of 57) of RhoGAP-GCs in the intramucosal area. MTMC histology showed high sensitivity and negative predictive value (93.0% and 99.4%, respectively) for RhoGAP fusion, albeit positive predictive value is low (34.9%).

Conclusion

RhoGAP-GC is linked to a characteristic MTMC histology and a high incidence of LNM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The datasets generated and/or analyzed during the present study are not publicly available in accordance with the policy of JFCR but may be available from the corresponding author by submitting a research proposal, which will be reviewed for scientific merit and feasibility.

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

    Article  PubMed  Google Scholar 

  2. Kwee RM, Kwee TC. Predicting lymph node status in early gastric cancer. Gastric Cancer. 2008;11:134–48.

    Article  PubMed  Google Scholar 

  3. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2021 (ver. 6). Gastric Cancer. 2023;26:1–25.

    Article  Google Scholar 

  4. Ono H, Yao K, Fujishiro M, Oda I, N Uedo, Nimura S, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021;33:4–20.

    Article  PubMed  Google Scholar 

  5. Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25.

    Article  PubMed  Google Scholar 

  6. Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.

    Article  PubMed  Google Scholar 

  7. Nakamura K, Sugano H, Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gan. 1968;59:251–8.

    CAS  PubMed  Google Scholar 

  8. Carneiro F, Fukayama M, Grabsch HI, Yasui W. Gastric adenocarcinoma. In: WHO Classification of Tumours Editorial Board. Digestive System Tumours, 5th ed. Lyon: International Agency for Research on Cancer; 2019;85–97.

  9. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 3rd ed. Gastric Cancer 2011;101–112.

  10. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.

    Article  Google Scholar 

  11. Osumi H, Kawachi H, Yoshio T, Ida S, Yamamoto N, Horiuchi Y, et al. Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy. J Gastroenterol. 2019;54:774–83.

    Article  PubMed  Google Scholar 

  12. Yang H, Hong D, Cho SY, Park YS, Ko WR, Kim JH, et al. RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer. Nat Commun. 2018;9:4439.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Zhang WH, Zhang SY, Hou QQ, Qin Y, Chen XZ, Zhou ZG, et al. The significance of the CLDN18-ARHGAP fusion gene in gastric cancer: A systematic review and meta-analysis. Front Oncol. 2020;10:1214.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Shu Y, Zhang W, Hou Q, Zhao L, Zhang S, Zhou J, et al. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer. Nat Commun. 2018;9:2447.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Nakayama I, Shinozaki E, Sakata S, Yamamoto N, Fujisaki J, Muramatsu Y, et al. Enrichment of CLDN18-ARHGAP fusion gene in gastric cancers in young adults. Cancer Sci. 2019;110:1352–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Tanaka A, Ishikawa S, Ushiku T, Yamazawa S, Katoh H, Hayashi A, et al. Frequent CLDN18-ARHGAP fusion in highly metastatic diffuse-type gastric cancer with relatively early onset. Oncotarget. 2018;9:29336–50.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.

    Article  CAS  PubMed  Google Scholar 

  18. Jaiswal M, Derewenda U, Reis K, Nouri K, Koessmeier KT, Aspenström P, et al. Deciphering the molecular and functional basis of r RhoGAP family proteins: a systematic approach toward selective inactivation of Rho family proteins. J Biol Chem. 2016;291:20353–71.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hodge RG, Ridley AJ. Regulating Rho GTPases and their regulators. Nat Rev Mol Cell Biol. 2016;17:496–510.

    Article  CAS  PubMed  Google Scholar 

  20. Komatsu M, Ichikawa H, Chiwaki F, Sakamoto H, Komatsuzaki R, Asaumi M, et al. ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer. Oncogene. 2022;41:4779–94.

    Article  CAS  PubMed  Google Scholar 

  21. Yao F, Kausalya JP, Sia YY, Teo AS, Lee WH, Ong AG, et al. Recurrent fusion genes in gastric cancer: CLDN18-ARHGAP26 induces loss of epithelial integrity. Cell Rep. 2015;12:272–85.

    Article  CAS  PubMed  Google Scholar 

  22. Hashimoto T, Ogawa R, Tang TY, Yoshida H, Taniguchi H, Katai H, et al. RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach. Mod Pathol. 2019;32:568–75.

    Article  CAS  PubMed  Google Scholar 

  23. Okamoto N, Kawachi H, Yoshida T, Kitagaki K, Sekine M, Kojima K, et al. “Crawling-type” adenocarcinoma of the stomach: a distinct entity preceding poorly differentiated adenocarcinoma. Gastric Cancer. 2013;16:220–32.

    Article  PubMed  Google Scholar 

  24. Ushiku T, Arnason T, Ban S, Hishima T, Shimizu M, Fukayama M, et al. Very well-differentiated gastric carcinoma of intestinal type: analysis of diagnostic criteria. Mod Pathol. 2013;26:1620–31.

    Article  CAS  PubMed  Google Scholar 

  25. Ushiku T, Ishikawa S, Kakiuchi A, Tanaka A, Katoh H, Aburatani H, et al. RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases. Gastric Cancer. 2016;19:403–11.

    Article  CAS  PubMed  Google Scholar 

  26. Sekiguchi M, Oda I, Taniguchi H, Suzuki H, Morita S, Fukagawa T, et al. Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancer. J Gastroenterol. 2016;51:961–70.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Ms. Miyuki Kogure, Ms. Tomoyo Kakita, Ms. Keiko Shiozawa, Ms. Mayumi Ogawa, Mr. Motoyoshi Iwakoshi, and Mr. Shuhei Ishii for their technical support.

Funding

This research was supported by the JSPS KAKENHI Grant Numbers JP16K08661 and JP21K06918.

Author information

Authors and Affiliations

Authors

Contributions

HN, SS, KT, and HK developed the study concept and design, interpretation of data, and statistical analysis and SS, SB, KT, and HK developed the methodology; HN, KN, CH, MT, ES, NY, and HK provided the histopathological diagnoses; HN, SS, KT, and HK wrote, reviewed, and revised the paper; TH, JF, and SN provided data acquisition. SB, YT, IN, and KI provided technical and material support. All the authors have read and approved the final manuscript.

Corresponding author

Correspondence to Hiroshi Kawachi.

Ethics declarations

Conflict of Interest

The authors declare no conflict of interest for this article.

Ethical approval

This study was approved by the institutional review board of the Japanese Foundation for Cancer Research (2022-GB-104). This study was conducted in accordance with the principles of the Declaration of Helsinki.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 34 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Noda, H., Sakata, S., Baba, S. et al. Early gastric cancer with RhoGAP fusion is linked to frequent nodal metastasis and a part of microtubular–mucocellular histology. Gastric Cancer (2024). https://doi.org/10.1007/s10120-024-01507-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10120-024-01507-4

Keywords

Navigation